| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |